President Donald Trump speaks at a Nov. 20 news conference in the briefing room at the White House (Susan Walsh/AP)

With on­ly weeks left in his pres­i­den­cy, Trump makes a fi­nal, long-shot bid to re­make US drug pric­ing

As the cur­tain clos­es on his ad­min­is­tra­tion, Pres­i­dent Don­ald Trump is us­ing his fi­nal weeks in of­fice to push one of his longest-run­ning cam­paign promis­es of low­er­ing pre­scrip­tion drug prices.

Trump an­nounced in a brief Fri­day news con­fer­ence that he would be in­sti­tut­ing the “most fa­vored na­tions” rule ty­ing prices in the US to those in oth­er de­vel­oped coun­tries, as well as end­ing cer­tain re­bates paid to mid­dle­men, al­so known as phar­ma­cy ben­e­fit man­agers, in Medicare. The two rules were part of a se­ries of four ex­ec­u­tive or­ders Trump un­veiled in Ju­ly aimed at tack­ling high pre­scrip­tion costs.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.